Floatz logo

Cyclophosphamide

Non-Alcoholic Fatty Liver Disease

Weill Medical College of Cornell UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
73/ 100

Competitive context

55 Active assets in the Non-Alcoholic Fatty Liver Disease cohort.

Asset / SponsorPhaseRating
Metformin
Xiqiao Zhou
Phase 4BBB
Pioglitazone
Badr University
Phase 4BBB
Semaglutide
Shanghai Jiao Tong University School of Medicine
Phase 4BB
Silymarin
University Hospitals Cleveland Medical Center
Phase 4BB
Letrozole
Jinnah Postgraduate Medical Centre
Phase 4BB

View all 50 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →